2026 One Mind Accelerator
Demo Day
Wednesday, April 15, 2026
1:00PM – 6:00PM
Allied Arts Guild
75 Arbor Road, Menlo Park, CA, 94025
Building the Future of Mental Health Together
The 2026 One Mind Accelerator brings together fourteen companies operating at the forefront of mental health innovation. This cohort is addressing the mental health crisis across the full continuum of severity and lifespan—from subclinical mental health challenges to serious mental illness, and from pediatric to geriatric care. Led by ambitious and determined founders, these companies are advancing therapeutic development, precision psychiatry, and novel mental healthcare models—delivering impact with speed, scale, and scientific rigor.
Meet the Startups
Biomia
Nature-inspired therapeutics for CNS disorders, including schizophrenia
+
Biomia is a biotech company developing a pipeline of novel, nature-inspired, human validated small molecule therapeutics to treat CNS disorders, including schizophrenia.
Michael Krogh Jensen, PHD
Co-Founder & CEO
Jie Zhang, PHD,
Co-Founder & CTO
Birches Health
Specialized, insurance-covered care for modern digital addictions
+
Birches Health is a digital behavioral health company that provides insurance-covered, specialized care for gambling, sex and pornography, video gaming, and internet and social media addiction.
Elliott Rapaport, MBA
CEO & Founder
Engram
Gen AI foundation model for precision psychiatry powered by multimodal patient biology
+
Eratos
AI-driven nanoscale brain mapping for precision-engineered CNS therapeutics
+
Eratos enables high-specificity therapeutic target identification through predictive, AI-driven nanoscale worldmaps of the brain, accelerating precision-engineered CNS drug discovery.
Brent Vaughan, MBA
Co-Founder & CEO
Ryan Shihabi
Co-Founder & Principal Engineer
Engram is building foundation models for precision psychiatry by comprehensively mapping phenotypic and biological disease subtypes to enable personalized treatment trajectories and precision drug discovery.
Joseph Lehar, PHD
Co-Founder, President & CEO
Nachiket Kashikar, PHD
Co-Founder, COO, CSO
Flow Neuroscience
FDA approved, at home, non-invasive brain stimulation treatment for depression
+
Flow Neuroscience is pioneering a new category of at-home electric medicine, delivering drug-free, brain-based mental health treatments—the world’s first clinically validated, FDA-approved at-home transcranial direct current stimulation headset.
Daniel Månsson
Co-Founder & CSO
Dr. Kultar Garcha
Chief Medical Officer
Forecast
Modeling mental health in a dish to speed up neuropsychiatric therapeutic development
+
Forecast Bio is building an AI-powered preclinical platform that directly links complex cellular neurobiology to patients’ mental health outcomes. By mapping how new drugs impact human brain circuits and symptoms, Forecast is speeding up therapeutic development by 10x.
Kira Poskanzer, PHD
CEO & Co-Founder
Maxine Levesque, PHD
Co-Founder & CTO
Limbic
The most clinically-validated AI agent for mental healthcare across the UK and US
+
Limbic is a clinically-validated AI agent for mental healthcare, used by health systems and payers across the UK and US. The AI has supported more than 600,000 patients in treatment, and is the only AI mental health chatbot approved as a Class II medical device.
Dr. Ross Harper, PHD
CEO & Founder
Manatee
Whole-family mental healthcare model to address the pediatric mental health crisis
+
Manatee is a family mental health provider addressing the pediatric mental health crisis by treating the entire family system, including parents. Manatee’s evidencebased, whole-family model is proven to be 4x more engaging and 3x more effective than traditional, child-only therapy.
Damayanti Dipayana
CEO & Co-Founder
Monument Therapeutics
Clinical-stage, precision drug development using validated digital biomarkers for brain disorders
+
Monument Tx is a neuroscience-focused biomarkers to develop more targeted treatments for neurological and psychiatric disorders, including schizophrenia
Jenny Barnett, PHD
CEO & Co-Founder
Kiri Granger, PHD
Co-Founder & CSO
Neurofundus is building foundation models for precision psychiatry by comprehensively mapping phenotypic and biological disease subtypes to enable personalized treatment
Joseph Lehár, PHD
CEO, President & Co-Founder
Nachiket Kashikar, PHD
Co-Founder, COO, CSO
Nosis
Integrative whole-person care for substance use addressing biological and psychological drivers
+
Nosis Health is a digital health company building a new model for substance use
care that integrates addiction medicine, advanced diagnostics, therapy, coaching, and lifestyle interventions, to build health and vitality, not just stopping use.
Duffy Fallon
CEO & Founder
Amy de la Garza, MD, DFASAM, IFMCP
Co-Founder & Chief Medical Officer
Orbit
Foundation models of cognitive states and conditions for precision mental healthcare
+
Orbit is building foundation models of cognitive states and conditions, enabling precision mental healthcare. Oribit is collecting unprecedentedly rich neural datasets, enabled by their novel brain wearable which can achieve fMRIcomparable resolution at scale.
Akshat Sharma
CEO & Co-Founder
Dipanshu Gandhi
Co-Founder, CTO
Radicle Science
Proven, precision mental wellness with highthroughput, scalable, real world clinical trials
+
Radicle Science fuses AI, consumer science, and massive real world clinical trials to scalably develop and validate effective, precise, nonprescription mental health treatments that are accessible to all.
Dr. Jeff Chen, MD, MBA
CEO & Co-Founder
Pelin Thorogood, MBA
Co-Founder & Executive Chairwoman
SocialRx
Healthcare-grade social prescribing for the dual mental health and loneliness epidemics
+
SocialRx is a healthcare-grade social prescribing platform that helps health plans, employers, and universities tackle the growing crisis of loneliness and mental health in the United States through arts, culture, and nature.
Chris Appleton, MBA
CEO & Founder
Vitalic
Geriatric-specialized, team-based behavioral health practice serving adults aged 65+
+
Vitalic Health is a geriatric-specialized and team-based behavioral health practice that uniquely provides the proactive outreach and engagement required to enroll and treat often reluctant 65+ members into behavioral health care.
Ben Gardner
CEO & Founder
Michelle Hoy, LCSW
Co-Founder & Head of Clinical Operations
Schedule
1:00 – 1:10 PM
Opening Remarks
Kathy Pike, PhD
CEO
One Mind
1:10 – 2:45 PM
Part 1: Frontiers in Mental Health Summit
1:10-1:30 PM
State of the Mental Health Market 2026: Forces, Trends, and Opportunities
Steve Duke
Founder
Hemingway
1:30 – 1:45 PM
GLP-1s and the Future of Metabolic Psychiatry for Severe Mental Illness
Scott Fears, MD, PhD
Chief Medical Officer, Amae Health
Professor of Psychiatry, UCLA
1:45 – 2:00 PM
Third-Generation Brain Computer Interfaces: Where Devices Meet Biology
Sumner Norman, PhD
Co-Founder
Merge Labs
2:00 – 2:15 PM
Neuroadaptive Intelligence for Brain Computer Interfaces and Mental Health
Maryam Shanechi, PhD
Alexander A. Sawchuk Chair in Electrical and Computer Engineering and Professor of Electrical and Computer Engineering, Biomedical Engineering, and Computer Science
University of Southern California
2:15 – 2:30 PM
Silicon Valley Wants to Fix Your Mind. Psychiatry Has Notes.
Nina Vasan, MD, MBA
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Founder and Director, Brainstorm: The Stanford Lab for Mental Health Innovation
Stanford University
2:30 – 2:45 PM
Audience Q&A with Drs. Fears, Norman, Shanechi, and Vasan
2:45 – 3:00 PM
Break
3:00 – 6:00 PM
Part 2: Demo Day & Networking Reception
3:00 – 3:55 PM
Pitches by Founders/ CEOs of the fourteen 2026 cohort companies
3:55 – 4:00 PM
Closing Remarks
Brandon Staglin
Co-Founder, Chief Advocacy & Engagement Officer
One Mind
4:00 – 6:00 PM
Interactive Demos & Networking Reception
Staglin Wine & Passed Appetizers Served for Reception
Building the
future of mental health together